The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Oxaliplatin given by hepatic arterial infusion (HAI) or systemic (SYS) with capecitabine in patients (pts) with unresectable liverlimited metastasis (Ur-LLM) from colorectal cancer (CRC).
Benny Vittrup Jensen
No relevant relationships to disclose
Henrik Noergaard
No relevant relationships to disclose
Magnus Bergenfeldt
No relevant relationships to disclose
Ole Larsen
No relevant relationships to disclose
Estrid Vilma Solyom Hoegdall
No relevant relationships to disclose
Jakob Johansen
No relevant relationships to disclose
Kirstine Hermann
No relevant relationships to disclose
Dorte Nielsen
No relevant relationships to disclose